kidney injury Eurofins Viracor, Cleveland Clinic Sign License Deal for Kidney Transplant Rejection Biomarker Test The test, which was developed by researchers at the Cleveland Clinic and the University of Alabama, looks for RNA molecules in urine that indicate rejection. CareDx, Weill Cornell Codeveloping Kidney Transplant Rejection Test The partners are planning to develop and commercialize UroMap, a urine-based gene-expression test for acute cellular rejection in kidney transplant recipients. CareDx Q1 Revenues Up 48 Percent The company reported $38.4 million in total revenues for the quarter and said testing services revenues rose 46 percent year over year. RenalytixAI, Mount Sinai Launch Study to Predict COVID-19 Kidney Complications Premium The firm believes the multi-part stratification project will help further commercialization of its KidneyIntelX blood-based assay for acute and chronic kidney disease. Natera Countersues CareDx for False Advertising CareDx first sued Natera in April 2019, accusing the company of trying to mislead patients and clinicians about the superiority of its Prospera transplant test. Jan 8, 2020 Magistrate Judge Recommends Partial Rejection of Natera Motion to Dismiss CareDx False Advertising Lawsuit Nov 19, 2019 Upgrades to CareDx's AlloSure Test Enable Earlier Detection of Transplant Rejection Premium Oct 31, 2019 CareDx Q3 Revenues Up 60 Percent Aug 22, 2019 CareDx AlloSure Kidney, Heart Tests Garner Palmetto Draft LCD Jul 18, 2019 Startup Nephrosant Aims to Launch Noninvasive Kidney Transplantation Test by Early 2020 Premium May 9, 2019 CareDx Plans to Launch New Multi-Modal Kidney Transplant Dx, Incorporating Predictive AI Premium Mar 26, 2019 CareDx, Stanford Sue Natera for Patent Infringement Mar 6, 2019 CareDx Q4 Revenues Increase 88 Percent Feb 25, 2019 CareDx Expands AlloSure Transplant Test to Lung, Starting With Compassionate Use Premium Aug 1, 2016 Natera, UCSF Partner to Study DNA Biomarkers of Kidney Transplant Rejection Oct 15, 2015 Astute Inks Deal With Shanghai Fosun for Chinese Distribution of NephroCheck, $20M in Financing Premium Aug 13, 2015 Sphingotec to Launch Protein Markers for Breast Cancer Risk in US This Year Premium Oct 17, 2014 With FDA Clearance of NephroCheck, Astute Secures Access to $30M from CRG Premium Sep 12, 2014 Astute Medical Receives FDA Clearance for NephroCheck Test, Begins Prepping US Launch Premium Apr 4, 2014 Muenster Study Indicates Astute's NephroCheck Can Help Predict AKI in Cardiac Surgery Patients Premium Mar 21, 2014 Astute Completes Multi-center Validation Study Supporting NephroCheck Test, 510(k) Submission Premium May 30, 2013 As Big Pharma Looks to Niche Diseases, RNAi May Benefit Premium Apr 4, 2013 NIH to Fund Acute Kidney Injury, Mental Disorder Research Projects with Potential miRNA Aspects Premium Feb 8, 2013 Multi-Site Validation Study Published Supporting Astute Medical's NephroCheck AKI Test Premium Oct 19, 2012 Astute Medical Launches European Sales of Nephrocheck AKI Risk Assessment Test Premium Load More Breaking News Bio-Rad Laboratories Q2 Revenues Climb 33 Percent, Beat Estimates Veracyte Q2 Revenues More Than Double on Test Volume Spike Increased Testing Revenues Boost Opko Health Q2 Revenues 47 Percent Qiagen Q2 Revenues Grow 28 Percent CareDx Q2 Revenues Up 77 Percent Secondary Genetic Findings Often Requested if Given Second Chance, Study Finds The Scan Booster Push New data shows a decline in SARS-CoV-2 vaccine efficacy over time, which the New York Times says Pfizer is using to argue its case for a booster, even as the lower efficacy remains high. With Help from Mr. Fluffington, PurrhD Cats could make good study animals for genetic research, the University of Missouri's Leslie Lyons tells the Atlantic. Man Charged With Threatening to Harm Fauci, Collins The Hill reports that Thomas Patrick Connally, Jr., was charged with making threats against federal officials. Nature Papers Present Approach to Find Natural Products, Method to ID Cancer Driver Mutations, More In Nature this week: combination of cryogenic electron microscopy with genome mining helps uncover natural products, driver mutations in cancer, and more.